All Curated Mutation Sites in HAV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HAV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
VP1
  
2A
  

Keyword: Acute Viral Hepatitis-18360890
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 18360890 Q810S
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
2 18360890 Q810A
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
3 18360890 M766T
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
4 18360890 M767V
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
5 18360890 S768G
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
6 18360890 E786K
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
7 18360890 R789K
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
8 18360890 P799L
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
9 18360890 P799S
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
10 18360890 R804G
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
11 18360890 L805M
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
12 18360890 V807A
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
13 18360890 K809R
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
14 18360890 A815G
VP1;2A
VP1;2A
Acute Viral Hepatitis
G
S
L
View
Contents
Description

The table shows all curated mutation sites of HAV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.